Inflammatory Nail Disorders
Inflammatory nail disorders are chronic, immune-mediated inflammatory reactions affecting one or more parts of the nail unit. What you see on the nail plate depends entirely on which anatomical structure is inflamed:
- Nail Matrix Inflammation:
- The matrix produces the keratinized cells (onychocytes) that build the nail plate. When lymphocytes (T cells) infiltrate the matrix, keratinization is disrupted.
- Proximal matrix: forms the upper surface of the nail plate. Inflammation here causes pitting or a rough, sandpaper-like surface (trachyonychia).
- Distal matrix: forms the underside of the nail plate. Inflammation here leads to white spots (leukonychia) or a thin, brittle nail that breaks easily.
- Nail Bed Inflammation:
- The nail bed lies beneath the nail plate. It is rich in blood vessels and has a thin epidermis firmly attached to the underside of the nail.
- When the nail bed epidermis becomes inflamed and keratinizes abnormally (parakeratosis), the nail plate lifts away from the bed (onycholysis) and thick keratin builds up underneath (subungual hyperkeratosis).
- Inflamed nail bed capillaries leak red cells, producing thin red to dark-brown lines running in the direction of nail growth (splinter hemorrhages).
Inflammatory nail conditions that are not caused by bacteria or fungi are often mistaken for nail fungus (onychomycosis) and needlessly treated with long courses of oral antifungals. At Haute-Derma, every workup includes direct microscopy/fungal culture (KOH/PAS stain) to rule out infection, together with nail dermoscopy (onychoscopy) to pin down the exact inflammatory condition (psoriasis, lichen planus or alopecia areata). This guides the choice between intralesional injection (ILI) and targeted biologic therapy.
Treatment Protocols and Medical Procedures at Haute-Derma
Treating nail inflammation takes patience because nails grow very slowly (fingernails about 3 mm/month, toenails 1–1.5 mm/month).
Topical Therapy
- For mild cases (NAPSI < 10 or fewer than 3 nails affected):
- Class I (super-potent) corticosteroid (clobetasol propionate 0.05%): applied to the proximal and lateral nail folds 1–2 times a day (gel or solution forms penetrate better).
- Vitamin D3 analog (calcipotriol 0.005%): combined with clobetasol propionate to reduce keratinocyte overgrowth in the nail bed.
- Calcineurin inhibitors (tacrolimus 0.1% / pimecrolimus 1%): a safe option for long-term use, avoiding steroid-related skin thinning.
Intralesional Injection (ILI) with Triamcinolone Acetonide: the gold standard for moderate to severe matrix inflammation and for nail lichen planus that threatens to scar:
Comfort measures: injections into the proximal nail fold are very painful, so we use a digital block or a high-pressure needle-free injector (Dermojet) to keep the patient as comfortable as possible.
Systemic and Biologic Therapy
Used when many nails are involved, when ILI has not worked, or when there is significant skin or joint disease:
- Oral systemic drugs: methotrexate (10–15 mg/week), acitretin (0.2–0.5 mg/kg/day), cyclosporine.
- JAK inhibitors (tofacitinib, baricitinib): particularly effective for trachyonychia and alopecia areata of the nails.
- Targeted biologics for psoriasis:
- IL-17 inhibitors (secukinumab, ixekizumab): among the highest rates of complete nail clearance reported in studies.
- IL-23 inhibitors (guselkumab, risankizumab) and anti-TNF-alpha agents (adalimumab).
